A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Trial ID or NCT#
NCT02954094
Status
RECRUITING
Purpose
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Official Title
A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- 1. Male or female patients, age ≥18 years 2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
Exclusion Criteria:
- 1. Inability to provide written informed consent
Investigator(s)
Paul Kwo
Hepatologist,
Transplant hepatologist,
Gastroenterologist
Professor of Medicine (Gastroenterology and Hepatology)
Contact us to find out if this trial is right for you.
Contact
Swati Toppo
650-497-4151
View on ClinicalTrials.gov
